John A. Sedor
2017
In 2017, John A. Sedor earned a total compensation of $1.2M as Chief Executive Officer at Pernix Therapeutics Holdings, a 35% decrease compared to previous year.
Compensation breakdown
| Bonus | $457,514 |
|---|---|
| Option Awards | $62,142 |
| Salary | $610,018 |
| Stock Awards | $27,800 |
| Other | $87,301 |
| Total | $1,244,775 |
Sedor received $610K in salary, accounting for 49% of the total pay in 2017.
Sedor also received $457.5K in bonus, $62.1K in option awards, $27.8K in stock awards and $87.3K in other compensation.
Rankings
In 2017, John A. Sedor's compensation ranked 7,931st out of 14,666 executives tracked by ExecPay. In other words, Sedor earned more than 45.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,931 out of 14,666 | 46th |
Division Manufacturing | 2,975 out of 5,768 | 48th |
Major group Chemicals And Allied Products | 974 out of 2,074 | 53rd |
Industry group Drugs | 760 out of 1,730 | 56th |
Industry Pharmaceutical Preparations | 597 out of 1,329 | 55th |
Source: SEC filing on April 9, 2018.
Sedor's colleagues
We found two more compensation records of executives who worked with John A. Sedor at Pernix Therapeutics Holdings in 2017.